11-124749813-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_014312.5(VSIG2):ā€‹c.481T>Cā€‹(p.Ser161Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000337 in 1,574,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000014 ( 0 hom., cov: 29)
Exomes š‘“: 0.000036 ( 0 hom. )

Consequence

VSIG2
NM_014312.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.858
Variant links:
Genes affected
VSIG2 (HGNC:17149): (V-set and immunoglobulin domain containing 2) Predicted to be located in membrane. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2847445).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
VSIG2NM_014312.5 linkuse as main transcriptc.481T>C p.Ser161Pro missense_variant 4/7 ENST00000326621.10 NP_055127.2 Q96IQ7-1
VSIG2NM_001329920.2 linkuse as main transcriptc.481T>C p.Ser161Pro missense_variant 4/6 NP_001316849.1 Q96IQ7-2
VSIG2XM_047426684.1 linkuse as main transcriptc.481T>C p.Ser161Pro missense_variant 4/5 XP_047282640.1
VSIG2XM_047426685.1 linkuse as main transcriptc.115T>C p.Ser39Pro missense_variant 2/5 XP_047282641.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
VSIG2ENST00000326621.10 linkuse as main transcriptc.481T>C p.Ser161Pro missense_variant 4/71 NM_014312.5 ENSP00000318684.5 Q96IQ7-1
VSIG2ENST00000403470.1 linkuse as main transcriptc.481T>C p.Ser161Pro missense_variant 4/62 ENSP00000385013.1 Q96IQ7-2

Frequencies

GnomAD3 genomes
AF:
0.0000139
AC:
2
AN:
143376
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000147
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000180
AC:
45
AN:
250490
Hom.:
0
AF XY:
0.000133
AC XY:
18
AN XY:
135462
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00131
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000356
AC:
51
AN:
1430810
Hom.:
0
Cov.:
32
AF XY:
0.0000281
AC XY:
20
AN XY:
711288
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00117
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000139
AC:
2
AN:
143376
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
69444
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000147
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000453
ExAC
AF:
0.000132
AC:
16

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 05, 2024The c.481T>C (p.S161P) alteration is located in exon 4 (coding exon 4) of the VSIG2 gene. This alteration results from a T to C substitution at nucleotide position 481, causing the serine (S) at amino acid position 161 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.024
T;.
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.54
T;T
M_CAP
Benign
0.044
D
MetaRNN
Benign
0.28
T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
0.51
N;N
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.28
N;N
REVEL
Uncertain
0.30
Sift
Benign
0.33
T;T
Sift4G
Benign
0.15
T;T
Polyphen
0.96
D;.
Vest4
0.65
MutPred
0.50
Loss of catalytic residue at S161 (P = 0.0018);Loss of catalytic residue at S161 (P = 0.0018);
MVP
0.63
MPC
0.27
ClinPred
0.15
T
GERP RS
-0.24
Varity_R
0.10
gMVP
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs777656524; hg19: chr11-124619709; API